trial summary · NCT06424522
A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients
Low Anterior Resection Syndrome: Retrograde Enema Program vs Medical Management
Trial record from the TrialBase DB dataset, status RECRUITING, condition Low Anterior Resection Syndrome, sponsored by Ohio State University Comprehensive Cancer Center. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
This clinical trial studies if a bowel management program with a retrograde rectal enema (RRE) for the treatment of low anterior resection syndrome (LARS) in rectal cancer patients is better than medical management alone. Rectal cancer treatment can include a procedure where part of the rectum with cancer is removed and the remaining part of the rectum is reconnected to the colon, this is called a low anterior resection of the rectum. LARS is a common condition that can develop after undergoing a low anterior resection of the rectum. LARS consists of any change in how the body performs defecation, the discharge of feces from the body, after undergoing a resection procedure. Patients with LARS may experience fecal urgency, incontinence, increased frequency, constipation, feelings of incomplete bowel movement, or bowel emptying difficulties. Patients may experience individual symptoms of LARS or a combination of them. A bowel management program assists patient's with identifying a specific bowel management regimen that works best for managing symptoms of LARS. A RRE consists of inserting a catheter through the anus into the rectum. The RRE is designed to assist fecal emptying. Medical management of LARS can include the use of fiber, loperamide hydrochloride, or pelvic floor physical therapy. Fiber may help relieve constipation, feelings of incomplete bowel movement, or bowel emptying difficulties. Loperamide hydrocholoride may help lessen fecal urgency, incontinence, or increased frequency. Pelvic floor physical therapy may help restore strength in the rectum possibly …
Source record: https://clinicaltrials.gov/study/NCT06424522
Facts
| registry id | NCT06424522 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | not reported |
| study type | INTERVENTIONAL |
| lead condition | Low Anterior Resection Syndrome |
| sponsor | Ohio State University Comprehensive Cancer Center |
| sponsor class | OTHER |
| enrollment | 80 |
| start date | 2027-02-15 |
| primary completion | 2028-12-31 |
| completion | 2028-12-31 |
| results posted | not reported |
Conditions
- Low Anterior Resection Syndrome
- Rectal Carcinoma
Interventions
- Dietary Fiber
- Enema Administration
- Loperamide Hydrochloride
- Physical Therapy
- Questionnaire Administration
- X-Ray Imaging
Countries
- United States
Intervention types: DIETARY_SUPPLEMENT, DRUG, OTHER, PROCEDURE
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.